Procedural decisions in the context of vascular substrate vulnerability: Lessons from vascular Ehlers-Danlos syndrome
- PMID: 40534705
- PMCID: PMC12174560
- DOI: 10.1016/j.jvscit.2025.101823
Procedural decisions in the context of vascular substrate vulnerability: Lessons from vascular Ehlers-Danlos syndrome
Conflict of interest statement
None.
References
-
- Pepin M.G., Schwarze U., Rice K.M., Liu M., Leistritz D., Byers P.H. Survival is affected by mutation type and molecular mechanism in vascular Ehlers-Danlos syndrome (EDS type IV) Genet Med. 2014;16:881–888. - PubMed
-
- Leistritz D.F., Pepin M.G., Schwarze U., Byers P.H. COL3A1 haploinsufficiency results in a variety of Ehlers-Danlos syndrome type IV with delayed onset of complications and longer life expectancy. Genet Med. 2011;13:717–722. - PubMed
LinkOut - more resources
Full Text Sources
